1. W. Schuphan, “Nutritional Value of Crops as Influenced by Organic and Inorganic Fertilizer Treatments. Results of 12 Years’ Experiments with Vegetables (1960–1972),” Qual. Plant P1. Fds. Hum. Nutr. 23, no. 4 (1974): 333–58.
2. Bob L. Smith, “Organic Foods vs Supermarket Foods: Element Levels,” Journal of Applied Nutrition 45, no. 1 (1993): 35–39.
3. “Body Burden: The Pollution in Newborns,” www.ewg.org/research/body-burden-pollution-newborns.
4. E. Fombonne, “The Prevalence of Autism,” JAMA 289 no. 1 (2003): 87–9; L. Wing and D. Potter, “The Epidemiology of Autistic Spectrum Disorders: Is the Prevalence Rising?” Ment Retard Dev Disabil Res Rev. 8, no. 3 (2002): 151–61.
5. Paul Kouchakoff, MD, “The Influence of Food Cooking on the Blood Formula of Man,” Proceedings: First International Congress of Microbiology, Paris 1930. Translation by Lee Foundation for Nutritional Research, Milwaukee, Wisconsin. Available in pdf form at www.igienenaturale.it/Post-PrandialLeucocytosis.pdf.
6. Victor Kulvinskas, “Don’t Dine without Enzymes,” a booklet available digitally at http://loveinservice.tripod.com/viktoraskulvinskas/id2.html.
7. Maynard Murray, MD, Sea Energy Agriculture (Austin, TX: Acres USA, 2003).
8. Bernard Jensen, Dr. Jensen’s Juicing Therapy: Nature’s Way to Better Health and a Longer Life (Lincolnwood, IL: Keats Publishing, 200).
1. Dr. William Davis, Wheat Belly (Toronto, ON: HarperCollins, 2011), 43–54.
2. I. Tomida et al., “Effect of Sublingual Application of Cannabinoids on Intraocular Pressure: A Pilot Study,” J Glaucoma 15, no. 5 (Oct 2006): 329–53; Alison Mack and Janet Joy, Marijuana as Medicine: The Science beyond the Controversy (Washington, DC: National Academies Press, 2001).
3. J. Thomas Ungerleider, et al., “Delta-9-THC in the Treatment of Spasticity Associated with Multiple Sclerosis,” Advances in Alcohol & Substance Abuse 7, no. 1 (1998), 39–50; John Zajicek et al., “Cannabinoids for Treatment of Spasticity and Other Symptoms Related to Multiple Sclerosis (Cams Study): Multicenter Randomised Placebo-Controlled Trial,” The Lancet 362 (Nov. 8, 2003), 1517–26; Derick T. Wade et al., “Do Cannabis-based Medicinal Extracts Have General or Specific Effects on Symptoms in Multiple Sclerosis? A Double-Blind, Randomized, Placebo-controlled Study on 160 Patients,” Multiple Sclerosis 10, no. 4 (August 2004), 434–41.
4. M. M. el-Sheikh et al., “The Effect of Permixon on Androgen Receptors,” Acta Obstet Gynecol Cand 67, no. 5 (1988), 397–99.
5. “Believed to Be World’s Oldest, Woman in France Dies at 122,” Houston Chronicle, August 4, 1997.
6. P. Bucheli et al., “Goji Berry Effects on Macular Characteristics and Plasma Antioxidant Levels,” Optom Vis Sci 88, no. 2 (February 1988): 257–62.
7. Jae-Dong Lee, et al., “An Overview of Bee Venom Acupuncture in the Treatment of Arthritis,” Evidence-Based Complementary and Alternative Medicine 2, no. 1 (2005) 79–84.
1. Romina Pedreschi et al., “Andean Yacon Root (Smallanthus sonchifolius Poepp. Endl) Fructooligosaccharides as a Potential Novel Source of Prebiotics,” Agric. Food Chem. 51, no. 18 (2003): 5278–84.
2. For just one example, Gilles-Eric Séralini, “Long Term Toxicity of a Roundup Herbicide and a Roundup-Tolerant Genetically Modified Maize,” Food and Chemical Toxicology 50, no. 11 (Nov. 2012), 4211–31.
3. Institute for Responsible Technology, “State-of-the-Science on the Health Risks of GM Foods.” Excellently referenced paper on current GMO research. Found online at www.saynotogmos.org/paper.pdf.
4. Jean Weiss, “12 Food Additives to Avoid,” MSN Health & Fitness, http://healthyliving.msn.com/nutrition/12-food-additives-to-avoid-1.
5. Mary G. Enig, “The Soy Controversy,” presented on May 25, 2001 at the 8th International Symposium of the Institute for Preventive Medicine in Vancouver, Canada. Summary available online at www.nutritions-playground.com/soycontroversy.
6. “Greenland Ice Core Reveals History of Pollution in the Arctic,” National Science Foundation press release 08–142, August 18, 2008, www.nsf.gov/news/news_summ.jsp?cntn_id=112074.
7. United States Environmental Protection Agency, “Water on Tap: What You Need to Know,” December 2009, United States Environmental Protection Agency, available at www.epa.gov/ogwdw/wot/pdfs/book_waterontap_full.pdf.
1. References for this hormone health section include the following: E. I. Barengolts et al., “Effects of Progesterone on Postovariectomy Bone Loss in Aged Rats,” Journal of Bone and Mineral Research 5, no. 11 (1990): 1143–47; E. I. Barengolts et al., “Comparison of the Effects of Progesterone and Estrogen on Established Bone Loss in Ovariectomized Rats,” Scanning Microscopy International, Cell and Materials Supplement 1 (1991), 108; Dr. John Lee and Virginia Hopkins, What Your Doctor May Not Tell You about Menopause (New York, NY: Warner Books, 2004); Dr. John Lee and Virginia Hopkins, What Your Doctor May Not Tell You about Pre-Menopause (New York, NY: Warner Books, 1991); Dr. John Lee and Virginia Hopkins, Dr. John Lee’s Hormone Balance Made Simple (New York, NY: Warner Books, 2006).
2. North American Menopause Society, “Estrogen and Progestogen Use in Postmenopausal Women: 2010 Position Statement of the North American Menopause Society, Menopause 17, no. 2 (2010): 242–55, www.menopause.org/PSht10.pdf; Million Women Study Collaborators, “Breast Cancer and Hormone-Replacement Therapy in the Million Women Study,” Lancet 362, no. 9382 (2003): 419–27; Women’s Health Initiative Steering Committee, “Effects of Conjugated Equine Estrogen in Postmenopausal Women with Hysterectomy,” JAMA, 291, no. 14 (2004): 1701–712; L. Speroff et al., “Menopause and the Perimenopausal Transition,” in Clinical Gynecologic Endocrinology and Infertility, 7th ed. (Philadelphia: Lippincott Williams and Wilkins Philadelphia: Lippincott Williams and Wilkins, 2005), 621–88; G. A. Bachmann et al., “Lowest Effective Transdermal 17beta-Estradiol Dose for Relief of Hot Flashes in Postmenopausal Women,” Obstetrics and Gynecology 110, no. 4 (2007): 771–79.
3. Olivia A. M. Franks, ND, and Jonathan V. Wright, MD, “Estriol: Its Weakness Is Its Strength,” Life Extension Magazine, August 2008. www.lef.org/magazine/mag2008/aug2008_Estriol-Its-Weakness-is-its-Strength_01.htm.
4. The source for this information on foods and breast cancer is D. T. Zava et al., “Estrogen and Progestin Bioactivity of Foods, Herbs, and Spices,” Proc Soc Exp Biol Med. 217, no. 3 (March 1998): 369–78.
5. Research in support of cannabis use to treat hormonal cancers includes María M. Caffarel et al., “Cannabinoids: A New Hope for Breast Cancer Therapy?” Cancer Treat Rev. 38, no. 7 (Nov. 2012): 911–18. Research against using cannabis for hormonal cancers includes S. Takeda et al., “Delta(9)-Tetrahydrocannabinol Enhances MCF-7 Cell Proliferation via Cannabinoid Receptor-Independent Signaling,” Toxicology 245, no. 1–2 (March 12, 2008): 141–46.
6. Dr. Daniel Cramer, “Coffee May Boost Estrogen Levels on Women,” Fertility and Sterility 76 (October 2001): 723–29.
7. Ray Peat, “Progesterone Summaries,” http://raypeat.com/articles/articles/progesterone-summaries.shtml.
8. International Osteoporosis Foundation, “Facts and Statistics,” www.iofbonehealth.org/facts-statistic.
9. H. S. Aiyer, “Dietary Berries and Ellagic Acid Diminish Estrogen-Mediated Mammary Tumorigenesis in ACI Rats,” Nutr Cancer 60, no. 2 (2008): 227–34.
10. Z. Papoutsi et al., “Evaluation of Estrogenic/Antiestrogenic Activity of Ellagic Acid via the Estrogen Receptor Subtypes ERalpha and ERbeta,” J Agric Food Chem. 53, no. 20 (October 5, 2005): 7715–20.
11. For more on I3C’s antiviral effects, see Terry Dorene Stoner, “Indole-3-Carbinol Inhibition of Herpes Simplex Virus Replication,” a December 2008 dissertation submitted to Kent State University, available at http://tinyurl.com/n3doq25.
12. Amy Norton, “Estrogen-like Lignan Diet, Less Breast Cancer Linked,” Reuters, June 4, 2010, http://tinyurl.com/mmlnqb3.
13. Here is the controversial Israeli study connecting melatonin to lowering estradiol: R. Luboshitzky et al., “Melatonin Administration Alters Semen Quality in Healthy Men,” J Androl. 23 no. 4 (July–Aug. 2002): 572–78. See also T. Kiefer et al, “Melatonin Inhibits Estrogen Receptor Transactivation and Camp Levels in Breast Cancer Cells,” Breast Cancer Res Treat 71 no. 1 (Jan. 2002): 37–45.
14. BioInitiative 2012 report, available at www.bioinitiative.org.
15. J. Zhao et al. “Antiaromatase Activity of the Constituents from Damiana (Turnera diffusa),” Journal of Ethnopharmacology 120 (December 2008): 387–93.
16. Rosário Monteiro, “Effect of Hop (Humulus lupulus L.) Flavonoids on Aromatase (Estrogen Synthase) Activity,” J. Agric. Food Chem. 54, no. 8 (2006): 2938–43.
17. J. Strathmann et al., “Xanthohumol from Hops Prevents Hormone-Dependent Tumourigenesis In Vitro and In Vivo,” Acta Hort. (ISHS) 848 (2009): 179–90.
18. M. M. el-Sheikh et al., “The Effect of Permixon on Androgen Receptors,” Acta Obstet Gynecol Cand 67, no. 5 (1988), 397–99.
19. D. T. Zava et al., “Estrogen and Progestin Bioactivity of Foods, Herbs, and Spices,” Proc Soc Exp Biol Med. 217, no. 3 (March 1998): 369–78.
20. G. Zhang et al., “Epimedium-derived Phytoestrogen Flavonoids Exert Beneficial Effect on Preventing Bone Loss in Late Postmenopausal Women: A 24-Month Randomized, Double-Blind and Placebo-controlled Trial,” J Bone Miner Res. 22, no. 7(2007): 1072–79.
21. M. M. el-Sheikh et al., “The Effect of Permixon on Androgen Receptors,” Acta Obstet Gynecol Cand 67, no. 5 (1988), 397–99.
1. The research results can be found at http://www.yourncdinfo.com/clinoptilolite-affinity-schedule.pdf. The same report states, “Clinoptilolite zeolite safely removes mercury, lead, tin, cadmium, arsenic, aluminum, antimony, nickel and all other toxic heavy metals.”